Clinical Trial Update: A Study to Assess the Effect of Erythromycin on the Test Medicine (SAR443820) When Given Orally as Tablets to Healthy Adult Male and Female Participants (Part A); and the Effect of Itraconazole on the Test Medicine (SAR443820) When Given Orally as Capsules to Healthy Adult Male Participants (Part B) [Phase 1]

View source ↗

Summary

This Phase 1 study evaluated the effect of erythromycin (Part A) and itraconazole (Part B) on SAR443820 pharmacokinetics when taken orally in healthy adult part…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• ERYTHROMYCIN (ERYTHROMYCIN)
• Itraconazole (Itraconazole)
• SAR443820

Snippet

Sponsor: Sanofi | Conditions: Amyotrophic Lateral Sclerosis, Healthy Volunteer | Phase 1 | Status: COMPLETED